logo-loader
NYSE:ADCT

ADC Therapeutics SA

Receive alerts
Market:
NYSE
Price
1.37 USD
Day Change
1.48%
Market Cap:
$192.71 m
52 weeks high
4.97
52 weeks low
0.78

In brief

ADC Therapeutics develops and commercialises antibody-drug conjugates for cancer. Its marketed product Zynlonta is used to treat certain patients with diffuse large B-cell lymphoma.